Fungal in Biological Technology

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... prior to CIMZIA use. Invasive fungal infections, including histoplasmosis , ... Patients with histoplasmosis or other invasive fungal infections may present with disseminated, rather ... be considered in patients at risk for invasive fungal infections who develop severe systemic illness. ...

Norgen Biotek Corp. Launches Four New Kits for the Purification of RNA and DNA from Plants and Fungi

... from a wide range of plant and filamentous fungal species. The Plant/Fungi RNA Purification Kit ... screening for plant pathogens. 4- The Direct fungal DNA Isolation Kit: This kit allows for the rapid ... of physical homogenization steps to isolate the fungal DNA, which are often time consuming and tedious ...

Fungitell(R) CE Marked, Referenced in IDSA and NCCN Guidelines and Added to EORTC-MSG Revised Definitions of Invasive Fungal Disease

... for the measurement of (1-->3)-beta-D-Glucan, a fungal cell wall component, has been CE marked, which ... a gram. The assay is used for patients at risk of fungal infection, including immuno-compromised patients, ... this invaluable aid in the diagnosis of invasive fungal infections." "The references to Fungitell(R) in ...

Foamix Signs Term Sheet to Acquire License to Organo-Boron Antifungal Molecules - Will Target the $11 Billion Dollars Fungal Infection Market

... are expected to be effective for onychomycosis, fungal infection of the fingernails and toenails, with ... and gynecological conditions, that involve fungal infection," commented Dov Tamarkin, Ph.D., ... a promising pathway for the treatment of fungal disease; and that the Ramot compounds will be ...

Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... Serious infections, including sepsis, pneumonia, tuberculosis, invasive fungal and other opportunistic infections have been observed with the use of ... For patients who have resided in or traveled to regions where invasive fungal infections such as histoplasmosis, coccidioidomycosis, or blastomycosis ...

Sirion Therapeutics Supplemental New Drug Application for Durezol(TM) to Treat Uveitis is Accepted for Review by the FDA

... patients with viral diseases of the cornea and conjunctiva, and those with fungal or mycobacterial infections of the eye or ocular structures. Prolonged use ... the severity of ocular viral infections, and increase the development of fungal infections of the cornea. It is important to monitor intraocular pressure ...

Lytix Closes USD 10.4 Million Funding Round

... novel lytic peptide drugs for the treatment of resistant bacterial and fungal infections, as well as first-in-class oncology treatments - both areas ... of skin infections, we envisage several other indications such as nail fungal infections, acne and oropharyngeal candidaisis. In oncology, LTX-315 ...

960-Patient Study Demonstrates Zero Blood Stream Infection In Patients Treated With Angiotech's Novel 5-FU Central Venous Catheter

... 0 6(x) ----------------------------------------------------- fungal species 0 2(x) ... performance without the risk of clinically meaningful bacterial or fungal resistance, a unique property among anti-infective coatings. "We are ...

Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis

... endpoint is complete cure, which is defined as 100% clear nails, negative fungal culture results and negative KOH microscopy. Arpida aims to demonstrate ... trial by early 2009." About onychomycosis Onychomycosis (OM) is a fungal infection affecting mainly toenails and, to a lesser extent fingernails. ...

SmartGene's Services for Faster, More Precise Identification of Bacteria and Fungi to be Used by The Johns Hopkins Hospital

... will utilize SmartGene's advanced technology and integrated Web-based services to support more rapid and precise identification of bacterial and fungal pathogens by sequence analysis. Some bacteria and fungi do not grow quickly or well enough in culture to support timely, accurate ...

NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference

... a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will present at the Jesup & Lamont 2009 Growth Stock ...

GlaxoSmithKline Completes Acquisition of Stiefel

... pipeline, with more than 15 projects in late-stage development across a wide variety of dermatological conditions, such as acne, dermatoses and fungal infection. The business unit also has access to significant innovative and proprietary formulation technologies. GlaxoSmithKline -- one ...

FDA Clears Caspofungin (Cancidas(R)) Susceptibility Testing for TREK Sensititre(R) YeastOne(R) in Vitro Diagnostics (IVD) Product Line

... of enzyme-inhibiting antifungal agents, caspofungin, is FDA-cleared for treatment of candidiasis in adults and pediatric patients. Candidiasis is a fungal infection that can be life-threatening if it becomes systemic. "This is the second FDA clearance we have received this year for our YeastOne ...

Australia: Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight

... Filligent designed the BioMask to withstand the rigours of pandemic logistics. Apart from being as affordable as standard masks, it is resistant to fungal contamination and extreme conditions, including humidity, heat or cold. It is flat-packed and can be surge manufactured. "We are working ...

Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD

... allergic reactions, facial swelling, hives, and throat tightness reported. Patients who use inhaled steroid medicines for asthma may develop a fungal infection of the mouth and throat. Rinse your mouth after using ASMANEX. It is possible that hypercorticism (an excess level of steroids in your ...

Scotland Highlights New Partnerships and Cutting-Edge Drug Discovery Research

... antifungal and antibacterial therapeutics, will also be on hand to discuss the development of its lead product Novexatin(TM), a novel treatment for fungal nail infection. Scottish Organizations at BIO Accuro Biologics Aquapharm Biodiscovery Ltd AvantiCell Science Ltd BioFilm ...

Divergence Receives $1.2 Million in Grants, Including NSF Grant to Fund Continuing Nematode Research in Corn

... Manufacturing Assistance Program Grant One USDA $350,000 Phase II Grant and two USDA $80,000 Phase I Grants for control of root knot nematodes and fungal infections in plants. Additionally, the National Corn Growers Association (NCGA) has provided research collaboration funding to the company for ...

Microtest Labs Expands Clean Room, Contamination Testing Services

... Compressed air/gas testing , including nonviable air particulate testing; compressed air testing for aerobic, anaerobic and fungal organisms; and testing for hydrocarbons and water vapors. For more information about Microtest Laboratories' complete offering of ...

SmartGene, Inc. Enters Collaboration with Virco Lab, Inc. to Enhance HIV Genotyping and Resistance Interpretation Services in US

... meets these needs," said David Ellis, President of SmartGene, Inc. "We have made excellent progress introducing our modules supporting bacterial and fungal identification by sequence analysis. As we expand the deployment of our services for virology in the US, we are delighted to enter this collaboration ...

GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business

... currently having more than 15 projects in late-stage development across a wide variety of dermatological conditions, such as acne, dermatoses and fungal infection. The new business also has access to significant innovative and proprietary formulation technologies. Charles Stiefel will continue in ...

NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions

... an extensive line of innovative medical, corrective and aesthetic solutions to treat a range of dermatological conditions including: acne, rosacea, fungal nail infections, psoriasis & other steroid-responsive dermatoses, pigmentary disorders, skin cancer and medical solutions for skin senescence. ...

Anacor Achieves Milestone from GSK for Boron-Based Systemic Antibacterial Product Candidate

... Anacor's most advanced product candidate is AN2690, a novel topical antifungal in development for the treatment of toenail onychomycosis, which is a fungal infection of the nail and nail bed. AN2690 is licensed to Schering-Plough Corporation under a worldwide development and commercialization agreement ...

Anacor Raises $50 Million in Equity Financing

... Anacor's most advanced product candidate is AN2690, a novel topical antifungal in development for the treatment of toenail onychomycosis, which is a fungal infection of the nail and nail bed. AN2690 is licensed to Schering under a worldwide development and commercialization agreement for all indications ...

Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million

... to be launched in the United States in early 2009. Dow has products in clinical development for the treatment of rosacea, moderate to severe acne, fungal infections and common warts. We expect one or more products to enter a Phase III trial in 2009, with an expected launch as early as 2012. In ...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

... please visit http://www.ucb-group.com . Tuberculosis (frequently disseminated or extrapulmonary at clinical presentation), invasive fungal infections, and other opportunistic infections, have been observed in patients receiving CIMZIA (R) . Some of these infections have been ...

Collegiate Inventors Competition(R) Recognizes Top Student Inventors

... and Diabetic Retinopathy - Potential to treat cancer and common issues associated with diabetes with Itraconazole, a drug typically used to treat fungal infections. Nathan Clack & Khalid Salaita, University of California at Berkeley (Advisor: Jay Groves) Electrostatic Readout of Microarrays - ...

Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontology's 94th Annual Meeting

... with SRP." About Ondine Biopharma Corporation Ondine is developing non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections. The Company is focused on developing and commercializing leading edge products utilizing its patented light-activated ...

Ondine Biopharma Announces Second Quarter 2008 Financial Results

... About Ondine Biopharma Corporation Ondine is developing non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections. The Company is focused on developing and commercializing leading edge products utilizing its patented light-activated ...

Immtech Reports Fiscal First Quarter 2009 Results

... treat infectious diseases. Immtech has a well defined, expanding library of compounds targeting Hepatitis C, drug-resistant Gram-positive bacteria, fungal infections and other serious diseases. It is expanding its targeted markets by applying its proprietary pharmaceutical platform to treat a range of ...

Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study

... About Ondine Biopharma Corporation Ondine is developing non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections. The Company is focused on developing and commercializing leading edge products utilizing its patented light-activated ...

Ondine to Present at Canaccord Adams 28th Annual Global Growth Conference

... 60 days. About Ondine Biopharma Corporation Ondine is developing non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections. The Company is focused on developing and commercializing leading edge products utilizing its patented light-activated ...

Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research

... Anacor's most advanced product candidate is AN2690, a novel topical antifungal in development for the treatment of toenail onychomycosis, which is a fungal infection of the nail and nail bed. AN2690 is licensed to Schering-Plough under a worldwide development and commercialization agreement for all ...

Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation

... began with Tobramycin added to 200 cc of saline. Today he often cultures the infection and adds the appropriate medications accordingly. For fungal infections, he use antifungals (such as Amphotericin B or Itraconazole). For inflammation, he adds an anti-inflammatory (such as Mometasone or ...

Barrier Therapeutics to Merge Into Stiefel Laboratories

... clinical development for the treatment of a range of dermatological conditions, including onychomycosis, psoriasis, acne, skin allergies, and acute fungal infections. The company is headquartered in Princeton, New Jersey and has a wholly-owned subsidiary in Geel, Belgium. More information about Barrier ...

Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China

... treat infectious diseases. Immtech has a well defined, expanding library of compounds targeting Hepatitis C, drug-resistant Gram-positive bacteria, fungal infections and other serious diseases. It is expanding its targeted markets by applying its proprietary pharmaceutical platform to treat a range of ...

Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference

... Anacor's most advanced product candidate is AN2690, a novel topical antifungal in development for the treatment of toenail onychomycosis, which is a fungal infection of the nail and nail bed. Anacor entered into a worldwide license, development and commercialization agreement for AN2690 with ...

Galderma Completes Acquisition of CollaGenex

... to improving the health of skin with an extensive line of products that treat a range of dermatological conditions including: acne, rosacea, fungal nail infections, psoriasis & steroid-responsive dermatoses, pigmentary disorders, medical solutions for skin senescence and skin cancers. With ...

Immune Function in Adult Heart Transplant Patients Reflects Risk for Organ Rejection and Infection

... from patients with no sign of infection (p < 0.001). Identified infections included 13 with a viral etiology; 15 with bacterial etiology; and 10 with fungal etiology. "Immune function monitoring of adult heart transplant patients using the ImmuKnow assay may have the potential to aid in the assessment ...

Nanosized technology has supersized effect on tumors

... in The FASEB Journal, the researchers describe a significant reduction of tumor growth in rabbits that were treated with nanoparticles coated with a fungal toxin called fumagillin. Human clinical trials have shown that fumagillin can be an effective cancer treatment in combination with other anticancer ...

QuoNova Global Executive Appointments

... data indicating high efficacy of selected QSBs in inhibiting biofilm formation by MRSA (methicillin-resistant Staphylococcus aureus) strains and fungal organisms such as Candida. Dr. Heiri Gugger, CEO of QuoNova, said: "The excellent progress continuing to be made by our scientific team in ...